Ron Alfa, MD, PhD’s Post

Register for the upcoming webinars this week! https://lnkd.in/dhmwB2h ➡ Qlucore Insights: Molecular classification of lung tumors from NGS data generated with standard tools and procedures (Feb 22) by Fredrik Hellborg Learn how the lung cancer model in Qlucore Insights can determine if a sample is from a lung tumor or if it is from metastasis. The webinar will cover the reasons why Qlucore uses transcriptomic data for classification, a description of our new lung cancer classifier for Qlucore Insights, and a live demonstration of the software that will cover the complete process, from the import of data to a report. ➡ Qlucore Omics Explorer: Analyze Luminex Data (Feb 22) by Matthew McGeough A Luminex® assay is a type of immunoassay that precisely measures multiple analytes in one sample. In this webinar we will demonstrate how to import data originated from a Luminex® panel, and how you can use statistical functions and plots to analyze the data. Luminex® is a registered trademark of Luminex Corporation. #qlucore #webinar #qlucoreinsights #qlucoreomicsexplorer #bioinformatics #training #ngs #lungcancer #cancerresearch #luminex

In our newest article, just published today, we make a significant step towards the application of the ball resonator biosensors, developed in our lab, in real-time detection applications. We have demonstrated the in-flow measurement of CD44 biomarker, even at low concentrations, in a dynamic context: the sensors respond in rapid way to the increment of concentrations, and do not suffer from artefacts such as packaging or influence of blood walls. While we still have a long way ahead, this shows an important upshift towards in-situ sensor placement for dynamic detection of cancer biomarkers; and I hope we can soon translate such results in a clinical settlement as there are applications demanding it. A big thanks to all the authors ZHULDYZ MYRKHIYEVA, Kanagat K., Aliya Bekmurzayeva, Anthony Gomez, Zhannat Ashikbayeva, Meruyert Tilegen, Tri Pham. You can read the paper open access on Sensors journal: https://lnkd.in/eNSyvFzM

🔬 NanoString Technologies, Inc. Technologies presents ground-breaking insights at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) ! Leading researchers, Dr. Aubrey Thompson and Amaya Pankaj, share initial data from NanoString's innovative GeoMx Immuno-oncology Proteome Atlas (IPA). This advanced spatial proteomics panel allows the unprecedented profiling of 570+ relevant targets in tissue sections. 🌟 Dr. Thompson's research explores early-stage HER2+ tumor biopsies, providing valuable insights into spatial biology in breast cancer. The GeoMx IPA assay offers five times more content than competing panels, opening doors to novel biomarkers, drug targets, therapeutic response investigations, patient stratification, and drug mechanism analysis. 🧬💡 Don't miss the IPA happy hour with NanoString's partners abcam and Visiopharm on November 3rd! #Biotech #CancerResearch #SpatialBiology #Proteomics #Innovation #Immunotherapy #Healthcare #NanoStringTechnologies 👩🔬📅🚀

Register for the upcoming webinar this week! https://lnkd.in/dhmwB2h Qlucore Insights: Automated molecular classification of Urothelial tumors (July 4) This webinar describes and demonstrates how Qlucore Insights classifies bladder tumor samples from standard whole transcriptome sequencing data. The first part will concentrate on the functionality of the software and the advantages gained from that. The second part will consist of a live demonstration of the software performing an analysis. #qlucore #webinar #qlucoreinsights #bioinformatics #cancerresearch

Cancer Diagnostics with Raman Spectroscopy! 🔬🩺 Discover the cutting-edge role of Raman spectroscopy and surface-enhanced Raman spectroscopy (SERS) in revolutionizing biomedical research and clinical diagnostics! Raman systems are also being developed for molecular diagnostic testing to detect and measure human cancer biomarkers. Read our application note to know more: https://brnw.ch/21wGXbd #CancerDiagnostics #RamanSpectroscopy #BiomedicalResearch #Metrohm #Biomedical #RamanSpectroscopy #Spectrsocopy #IRaman #BWTEK #ClinicalResearch #MetrohmIndia

Looking to enrich your cancer research with the latest advancements in urine liquid biopsy and neoantigen discovery for cancer immunotherapy? 📢 Join our Spotlight Theater presentation: April 8, 2024, from 10 a.m. to 11 a.m. PDT, Room D. What are the sessions about? • Session 1 – Evaluation of preanalytical workflows for molecular profiling of urinary cell-free DNA in malignant disease (Presenter: Ellen Heitzer, PhD, Medicinal University Graz, Austria) • Session 2 – Uncovering immunogenic neo-peptides from actionable RNA fusions for cancer immunotherapy (Presenter: Sakuni Rankothgedera, University of Houston)

Advance multi omics data analysis and precision medicine through our free webinars. New webinars added. Register - https://lnkd.in/dhmwB2h August 27 🚀Using Public Data and Tools: What can TCGA, MSigDB and NDEx / Cytoscape can do for your Omics Research August 29 🚀 Qlucore Insights: Identify the tissue of origin for lung lesions September 12 🚀Efficient Biomarker Testing– Identify Effective Drug Candidates, Treatments and Signals in your Omics Data September 19 🚀 Qlucore Omics Explorer: Multi-omics data analysis combining transcriptomics and proteomics data September 26 🚀 Qlucore Insights: Automated expression profiling for the classification of acute lymphoblastic leukemia #qlucore #webinar #bioinformatics #singlecell #rnaseq #precisionmedicine #cancerresearch

Accelerate your pipeline development journey with g.nome™, a single platform that seamlessly guides you from data to discovery. UT Southwestern Medical Center's Corey Lab experienced the efficiency of g.nome firsthand: within a span of just two weeks, the lab was not only able to assemble and run their pipeline, but they also managed to analyze intricate RNA sequencing data. Studying the complexities of cancer cell lines at varying densities requires flexibile iteration, and g.nome empowered the lab to swiftly pinpoint biologically significant events and identify miRNA binding sites. By streamlining a typically time-consuming process, g.nome empowers researchers to pivot and iterate swiftly, facilitating invaluable insights into cancer biology for impactful drug discovery and development. Read the full case study: https://lnkd.in/g7drCC25 #genomicsequencing #drugdiscovery

Tumor Heterogeneity, Phenotype Plasticity & Off-target Mechanism serve as the most complex challenges in cancer treatment, while the lack of analytic platform with ultra-resolution hinder the development of Precision Oncology Research, New Drug Development and Personalized Treatment. Our AI Drug Screening Platform at single cell level allows biologists conduct high throughput drug screening on millions of single cancer cells, followed by multi-dimensional single cell analysis (i.e. genomics, proteomics, morphology and drug resistance). The entire pipeline takes less than 24 hours to identify tumor subpopulation population based on our continuous observation by our proprietary AI algorithm, Provectus.AI. Find out more on : https://lnkd.in/gpPZVfjx Find out more on : https://lnkd.in/gpPZVfjx #singlecellanalysis #precisiononcology #ai #drugscreening

Cancer Profiling Market worth $16.0 billion by 2027 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/d_9iuG3d The global #cancer #profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 billion by 2027, growing at a CAGR of 10.6% from 2022 to 2027. #biotechnologyindustry Illumina. QIAGEN NeoGenomics Laboratories Sysmex Corporation HTG Molecular Diagnostics Predictive Oncology (Helomics) Caris Life Sciences NanoString Technologies, Inc. Guardant Health Foundation Medicine F. Hoffmann-La Roche Ltd Thermo Fisher Scientific GenScript Tempus AI Hologic, Inc. Exact Sciences Labcorp Personalis, Inc. Boreal Genomics Strand Life Sciences Lucence ACT Genomics (行動基因) IMBdx Perthera AI Agendia